Article citationsMore>>

Pop-Busui, R., Boulton, A.J., Feldman, E.L., Bril, V., Freeman, R., Malik, R.A., Sosenko, J.M. and Ziegler, D. (2016) Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care, 40, 136-154.
https://doi.org/10.2337/dc16-2042

has been cited by the following article:

• TITLE: Evaluation in Diagnosis and Management of Diabetic Neuropathy

  AUTHORS: Wendy Waldman Zadeh, Pichit Thanupakorn

  KEYWORDS: Diabetic Neuropathy, Glycemic Control, Glycation End Products, Neuropathy Pain Medications, Preventive Medicine, Socioeconomic Status

  JOURNAL NAME: Journal of Diabetes Mellitus, Vol.11 No.5, November 18, 2021

  ABSTRACT: The 100-year anniversary of insulin is explored by focusing on diabetic neuropathy. Neuropathy is so common to diabetes, it is well described even in the earliest accounts of diabetes. This article reviews the most common neuropathy syndromes, and the consensus of effective treatment for neuropathic pain. Pharmacological advances in neuropathy are still largely focused on pain control, not neuropathy intervention. The article reviews the established and lesser tested therapies used for pain control. It also reviews the pathophysiology of the disease state, including the many factors and steps that culminate to produce neuropathy and its different iterations. In the future, new ways to treat diabetic neuropathy may be geared toward treating specific pathophysiological step-points on the way to nerve damage. In the future, prevention and a deeper look at the impact of socioeconomic status as a predictor of diabetes will hopefully encompass a bigger part of pre-diabetic care.